2 Minute Medicine

No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Cabozantinib Improved Progression-Free Survival in Advanced Neuroendocrine 2m -m Tumors

byJinny TsangandAlisha Yi

October 1, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

2 Minute Medicine Rewind July 13, 2026

New targeted therapy daraxonrasib improves survival in pancreatic cancer

2 Minute Medicine: Pharma Roundup – Geopolitical instability in the Strait of Hormuz threatens global generic drug supply, daraxonrasib improves pancreatic cancer survival, sparsentan (Filspari) approved for focal segmental glomerulosclerosis, glucagon-like peptide-1 receptor agonists linked to reduced substance use disorders, and orforglipron (Foundayo) expands oral weight loss therapy options

Tags: cabozantinib efficacy neuroendocrine tumor pancreatic cancer progression-free surivival rct safety

The Scan by 2 Minute Medicine®: Concussion Protocol, Monstrous Mosquitoes, Eye Transplants and Taking on 23andMe:

Newly discovered orthonairovirus is associated with human febrile illnesses

RelatedReports

Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial

Weekly Rewinds

2 Minute Medicine Rewind July 13, 2026

Oncology

New targeted therapy daraxonrasib improves survival in pancreatic cancer

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Pharma

2 Minute Medicine: Pharma Roundup – Geopolitical instability in the Strait of Hormuz threatens global generic drug supply, daraxonrasib improves pancreatic cancer survival, sparsentan (Filspari) approved for focal segmental glomerulosclerosis, glucagon-like peptide-1 receptor agonists linked to reduced substance use disorders, and orforglipron (Foundayo) expands oral weight loss therapy options

Hybrid minimally invasive esophagectomy associated with lower complication rates compared to open esophagectomy

Chronic Disease

Camrelizumab may be safe and effective in the management of locally advanced esophageal squamous cell carcinoma

Next Post

Newly discovered orthonairovirus is associated with human febrile illnesses

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults

Adjunctive treatment with argatroban or eptifibatide does not improve post-stroke functional outcomes

Drug-coated balloons are noninferior to drug-eluting stents for treatment of small vessel coronary artery disease

Optical coherence tomography-guided angioplasty reduces adverse events compared to angiography guidance

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.